Ainos, Inc. (AIMD)
NASDAQ·Healthcare·Biotechnology
$2.09
+11.17%
Mkt Cap $7.14M
No analyst coverage available
We don't have analyst ratings or price target data for Ainos, Inc. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.